SpCas9 D10A Nickase
$640.00 - $1,280.00
$1,600.00
All products have special prices for bulk purchase, please contact for more details if required.
Cat. No.: Cas9DAN-100 (for 100pmol)
Cat. No.: Cas9DAN-1k (for 1000pmol)
Description
SpCas9, derived from the S. pyogenes strain, is a DNA endonuclease guided by crRNA and tracrRNA (or the fused sgRNA). In the presence of a PAM (NGG) sequence in the target double-stranded DNA, SpCas9 selectively cleaves the target DNA, causing a break in the DNA double-strand and generating blunt ends. PAM is essential for both the recognition and cleavage of SpCas9, with the cleavage site located within the target sequence, three bases away from the PAM region. The HNH and RuvC domains of the SpCas9 enzyme are responsible for cleaving the strands of the target double-stranded DNA that are paired and unpaired with sgRNA, respectively. In this product, the D10 of SpCas9 is mutated to A, rendering its RuvC domain inactive. Therefore, SpCas9 D10A Nickase only retains cleavage activity in the HNH domain, cutting the target strand (TS) of the dsDNA and creating a single-strand nick.
Storage
Recommended to be stored at -20°C.
Q1: What are the differences between nCas9 and Cas9?
A1: Cas9 can recognize and cleave double-stranded DNA (dsDNA) targets, involving the HNH and RuvC domains. HNH cleaves the target strand (TS), RuvC cleaves the non-target strand (NTS), and together, they generate double-strand breaks (DSBs) in dsDNA, creating blunt ends. However, nCas9, due to amino acid mutations like H840A or D10A, results in the inactivation of either the HNH or RuvC domain. As a consequence, nCas9 can only cut one strand of the target dsDNA, creating a single-strand break. Specifically, SpCas9 H840A Nickase can only cleave the non-target strand (NTS) of the target dsDNA that is not complementary to sgRNA, while SpCas9 D10A Nickase can only cleave the target strand (TS) that is complementary to sgRNA. Additionally, there is dCas9, where mutations in both H840A and D10A render dCas9 incapable of cleaving either strand of the target dsDNA, only allowing binding.
Q2: How should sgRNA for nCas9 be designed?
A2: The sgRNA for nCas9 can be designed using the following sequence: 5′–NNNNNNNNNNNNNNNNNNNNUUUCGUGGCUGAGCCACGGUGAAAAAGUUCAACUAUUGCCUGAUCGGAAUAAAAUUGAACGAUAAAGAUCGAGAUUUUG–3′ (Underscores indicate the spacer region complementary to the specific target sequence).
SBS Genetech is recognized as one of the global major leading industry players in Gene Editing by third-party market researchers. For more details, please visit Global Gene Editing Service Market 2019 by Company, Regions, Type and Application, Forecast to 2024.
Related: Synthetic sgRNAs